Jose A. Diaz-Buxo MD, Dixie-Ann Sawin PhD, Rainer Himmele MD
{"title":"PD solutions: New and old","authors":"Jose A. Diaz-Buxo MD, Dixie-Ann Sawin PhD, Rainer Himmele MD","doi":"10.1002/dat.20601","DOIUrl":null,"url":null,"abstract":"<p>Peritoneal dialysis (PD) solutions have evolved since Boen described the appropriate composition of a suitable fluid comprising an osmotic agent, electrolytes, and buffer substance in 1969. New solutions introducing alternative osmotic agents and bicarbonate as an alternative to lactate-buffered solutions have been developed. These so-called biocompatible solutions belong to a very heterogeneous group of PD fluids that share some features but are distinct in other aspects. All biocompatible solutions have a substantially reduced level of toxic glucose degradation products (GDPs). However, the new solutions differ in their absolute GDP content, osmotic agent, buffer substance, and pH. The differences from the conventional solutions and the characteristics of the distinct new solutions are presented in this review together with a discussion of their potential clinical benefits and implications. Dial. Transplant. © 2011 Wiley Periodicals, Inc.</p>","PeriodicalId":51012,"journal":{"name":"Dialysis & Transplantation","volume":"40 8","pages":"356-363"},"PeriodicalIF":0.0000,"publicationDate":"2011-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/dat.20601","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dialysis & Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dat.20601","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Peritoneal dialysis (PD) solutions have evolved since Boen described the appropriate composition of a suitable fluid comprising an osmotic agent, electrolytes, and buffer substance in 1969. New solutions introducing alternative osmotic agents and bicarbonate as an alternative to lactate-buffered solutions have been developed. These so-called biocompatible solutions belong to a very heterogeneous group of PD fluids that share some features but are distinct in other aspects. All biocompatible solutions have a substantially reduced level of toxic glucose degradation products (GDPs). However, the new solutions differ in their absolute GDP content, osmotic agent, buffer substance, and pH. The differences from the conventional solutions and the characteristics of the distinct new solutions are presented in this review together with a discussion of their potential clinical benefits and implications. Dial. Transplant. © 2011 Wiley Periodicals, Inc.
PD解决方案:新的和旧的
自1969年Boen描述了由渗透剂、电解质和缓冲物质组成的合适液体的适当组成以来,腹膜透析(PD)溶液不断发展。新的解决方案引入替代渗透剂和碳酸氢盐作为替代乳酸缓冲溶液已经开发。这些所谓的生物相容性溶液属于一组非常异质的PD液,它们有一些共同的特征,但在其他方面却截然不同。所有生物相容性溶液的毒性葡萄糖降解产物(gdp)水平都大大降低。然而,新溶液在绝对GDP含量、渗透剂、缓冲物质和ph值方面存在差异。本文将介绍与传统溶液的差异以及不同新溶液的特点,并讨论其潜在的临床益处和意义。拨号。移植。©2011 Wiley期刊公司
本文章由计算机程序翻译,如有差异,请以英文原文为准。